<DOC>
<DOCNO>
EP-0004770
</DOCNO>
<TEXT>
<DATE>
19791017
</DATE>
<IPC-CLASSIFICATIONS>
A61P-37/00 A61K-31/23 A61K-31/425 A61K-31/43 A61K-33/30 A61K-45/00 A23L-1/30 A61K-45/02 A61K-31/34 A61K-31/202 A61K-38/21 A61K-31/475 A61P-13/02 A61K-31/315 A61P-13/00 A61K-31/429 A61K-38/00 A61P-35/00 A61K-31/155 A61K-31/40 A23L-1/29 A61P-15/00 A61K-31/185 A61K-31/20 <main>A61K-31/20</main> A61K-31/21 A61P-29/00 A61K-31/557 A61P-43/00 A61K-45/06 
</IPC-CLASSIFICATIONS>
<TITLE>
pharmaceutical and dietary composition comprising gamma-linolenic acids.
</TITLE>
<APPLICANT>
efamol ltdgb<sep>efamol limited<sep>efamol limited71/74 mark lanelondon e.c.3gb<sep>efamol limited<sep>
</APPLICANT>
<INVENTOR>
horrobin david frederick<sep>horrobin, david frederick<sep>horrobin, david frederick110 pine avenue westmontrealca<sep>horrobin, david frederick<sep>horrobin, david frederick110 pine avenue westmontrealca<sep>
</INVENTOR>
<ABSTRACT>
compositions and use of α-linolenic acid and related  materials with (i) zinc, β-lactam antibiotics or other materials  enhancing physiological 1-series pg synthesis and/or (ii)  colchicine, vinca alkaloids or other materials enhancing  physiological synthesis of thromboxane a2, for treatment of  cancer or inflammatory disorders.  
</ABSTRACT>
</TEXT>
</DOC>
